NIH Announces Change Concerning Notices of Funding
The National Institutes of Health (NIH) issued a policy notice to announce that notices of funding opportunities (NOFOs) will no longer be published in the NIH Guide for Grants and Contracts, more commonly referred to as the NIH Guide, beginning in FY 2026. Moving forward, Grants.gov will serve as the NIH’s single official source for funding opportunities.
Updates from the NIH Office of Research on Women’s Health
Women’s health is one of the Endocrine Society’s top policy and advocacy priorities. We want to bring your attention to the following updates and information:
- Sex as a Biological Variable (SABV): The SABV policy at NIH provides framework for NIH-funded researchers to account for sex as a biological variable in human and vertebrate animal studies. While many NIH policies are changing, we understand that the SABV policy remains in effect at NIH. The Endocrine Society championed the introduction SABV policy at NIH and applauds the continuation of this policy across NIH ICs.
- DiscoverWHR: A new resource is available to serve as a place for individuals to find information on menopause, polycystic ovary syndrome, ovarian cancer, and more that affect women’s health across the lifespan. Individuals can also find information on clinical trials related to these areas of health on this website.
- NIH-Wide Strategic Plan for Autoimmune Disease Research: The Office of Autoimmune Disease Research within ORWH recently released their NIH-Wide Strategic Plan for Autoimmune Disease Research. With over 140 identified autoimmune diseases affecting every organ system, 25% of individuals having more than one autoimmune disease, and over 80% of individuals with an autoimmune disease are women, this strategic plan identifies five priorities which will be used to guide autoimmune research across NIH’s Institutes and Centers.
- Small business grant funding opportunities: ORWH has partnered with the Small Business Innovation (SBIR) and Small Business Technology Transfer (STTR) programs, also known as America’s Seed Fund, FDA, and CDC to solicit researcher-initiated proposals through the to support small businesses and innovators supporting women’s health research and development. The Notice of Special Interest (NOSI) for Women’s Health Research expires on September 8, 2025.
